{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-037159","form_type":"8-K","ticker":"INFU","cik":"0001337013","company_name":"InfuSystem Holdings, Inc","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.695091+00:00","generated_at":"2026-06-08T14:06:08.863219+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"InfuSystem Q3 revenue $31.9M (+17% YoY), net income up 56%, raises FY 2023 guidance","bullets":["Net revenues $31.9M (+17% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M prior year.","Adjusted EBITDA $6.2M (+11% YoY); FY 2023 net revenue growth guidance raised to >11% (from >10%).","Patient Services revenue $19.3M (+11%), Device Solutions $12.6M (+27%); gross margin fell to 50.9% from 59.5%.","Operating income increased 80%; record revenue for seventh consecutive quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-037159","json":"https://secwatch.observer/filing/0001628280-23-037159.json","markdown":"https://secwatch.observer/filing/0001628280-23-037159.md","text":"https://secwatch.observer/filing/0001628280-23-037159.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/0001628280-23-037159-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/infu-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T14:06:08.863219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f0490bf12900e7abf03bcff708d2eb7fdcf5fc0","claim":"InfuSystem Holdings, Inc reported third quarter ended September 30, 2023 results: revenue $31.9 million, net income $0.7 million, or $0.03 per diluted share, EPS $0.03 per diluted share. Guidance raised.","evidence_excerpt":"InfuSystem Reports Third Quarter 2023 Financial Results Record Net Revenues of $31.9 million Representing 17% Growth from the Prior Year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/0001628280-23-037159-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$31.9 million"},{"label":"Net income","value":"$0.7 million, or $0.03 per diluted share"},{"label":"EPS","value":"$0.03 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}